28
Oct
2025

PENMIX Co. Ltd.

Exhibitor at CPHI Frankfurt 2025 stand 6.1C58, Contract Manufacturing and Services
About Us

PENMIX maximizes the business efficiency by conducting the whole process of research planning, development, licensing, manufacturing, and so on. As we are an organization specialized in General Injectable plant and we have our own R&D and RA specialists for whole CMO/CDMO project management. Among the injectable formulations, we are specialized in the following formulations: Auto/Pen Injector, Cartridge, Liquid, Lyophilized, Powder Vial, PFS. We have EUGMP, JGMP, and KGMP as GMP certification status and plan to prepare cGMP with the goal of exporting to US in 2026.

  • KR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 6.1C58, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • Daptomycin

    Product Daptomycin

    For treatment of bloodstream infection (bacteremia) associated with right infective endocarditis caused by Staphylococcus aureus(including methicillin sensitivity and methicillin resistance). 
  • Ferric Carboxymaltose

    Product Ferric Carboxymaltose

    Under development for global market
  • Sugammadex

    Product Sugammadex

    200mg/2mL500mg/5mL